Society for Translational Oncology

New podcast! 🎙️ Voices in Oncology launches with “Oncology Nurse Navigation: Breaking Barriers Beyond Treatment.” #VoicesInOncology #OncologyNursing #CancerCare #Patient Navigation Listen here: buff.ly/7HsZAqL

Prevalence and Factors Associated With Financial Toxicity Among Patients With GI Cancer in Pakistan | JCO Global Oncology buff.ly/TV1QnVv

Today is Clinical Trials Day. At STO, we recognize the value of clinical research and the need for trials that are accessible, inclusive, and relevant to real-world patients. #ClinicalTrialsDay #ResearchRising #CTD2026 #STO

Political will and government commitment are essential to tackle Africa’s growing cancer burden - through national policies, dedicated funding, expanded screening, a trained workforce and improved treatment access. Read more: buff.ly/iIORPUW #CancerCare #Africa

Financial Toxicity in Cancer Care: Why the Conversation Must Start Before Treatment Begins - Oncology Practice Management buff.ly/Mer6Lrh

Fall prevention in older patients with cancer: A call for action on behalf of the European Geriatric Medicine Society Special Interest Group on Gero-Oncology geriatriconcology.net/article/S1879-… @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier #Aged #Frailty

Twitter / X “Progress depends not only on clinical capacity, but also on political will.” In a new STO expert perspective, @roseanorlu examines the role of government commitment in scaling equitable cancer care across Africa. buff.ly/jyI7Tgj #GlobalHealth #CervicalCancer

Who Can Benefit From a Cancer Genetic Evaluation? Considerations for Genetic Risk Evaluation and Testing Based on Tumor Type and Pathology | JCO Oncology Advances buff.ly/ntOQMN7

New paper in @NatRevClinOncol ! We propose “time budgeting” as a new design principle for cancer care: treating patient time as a finite resource that should be measured, protected, and incorporated into care pathways & clinical trials. Because time is also a toxicity. ⏳

By 2040, Africa could face 2.1M+ new cancer cases annually. Medicines and evidence exist, but access is not automatic. Our latest STO article explains what it takes to deliver care at scale. buff.ly/cmR3Ovj #ClinicalTrialsDay #CTD2026 #ResearchRising #GlobalOncology

FDA Clears At-Home HPV Self-Collection Kit to Expand Cervical Cancer Screening Access | CancerNetwork buff.ly/1izd4bl

Wearables Bring Real-Time Insight into Oncology and Medicine | The Scientist buff.ly/0f2AZhl

How Geriatric Assessments Can Benefit Older Adults with Cancer buff.ly/XAUvVfD

Projecting Individualized Probabilities of Lifetime Total Cancer Risk Across a Population | JCO Oncology Advances buff.ly/2dglWXg

“Our Community is not Appropriately Served”: LGBTQ+ Cancer Survivors and Caregivers have Suggestions for Providers

Reflecting on 25 years of SPIKES: bad news communication in our modern era | The Oncologist | Oxford Academic buff.ly/HfO1V64

Cervical cancer screening fails when results require return visits. The fix: connected systems. STO's World Health Day blog on HPV testing, AI triage, and point-of-care innovations that close the follow-up gap. buff.ly/vqsPBgY

🌍 April 7 is #WorldHealthDay! This year's theme: Together for health. Stand with science. 💙 At STO, we believe science saves lives, and so does solidarity. Join us in standing for a healthier world. RT to spread the message! #StandWithScience #TogetherForHealth

We stand alongside the @‌Prevent Cancer Foundation to recognize Cancer Prevention and Early Detection Month! Raise awareness with us this April about the importance of cancer prevention & early detection: bit.ly/3Ob5VAP

Online Decision Support for Implementing Evidence-Based HPV Vaccination Strategies in Texas Safety-Net Pediatric Clinics: Impact on HPV, MCV, and Tdap Initiation - PMC buff.ly/fsy7qDP